Showing results (41-50 of 682) with videos related to
Sort By:
Pageof 69
Blood|December 1, 1983
Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell propertiesJ D Griffin, P Larcom, S F SchlossmanHybridoma|January 1, 1983
Novel approach to construction of human "myeloma analogues" for production of human monoclonal antibodiesM R Posner, S F Schlossman, H LazarusJournal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytesP Anderson, M L Blue, S F SchlossmanThe Journal of Experimental Medicine|November 1, 1975
T and B cell in hapten-specific carrier-determined toleranceY Borel, C L Reinisch, S F SchlossmanThe Journal of Experimental Medicine|June 1, 1971
Antigen recognition and antibody specificity. Carrier specificity and genetic control of anti-dinitrophenyl-oligolysine antibodyH A Levin, H Levine, S F SchlossmanJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1982
T cell and IR gene regulation of expression of a cross-reactive idiotypeM C Bekoff, H Levine, S F SchlossmanActa Medica Scandinavica|January 1, 1980
The diagnosis of atrial myxomas. Difficulties and pitfallsD Schlossman, K Selin, J Wallin, et al.Cellular Immunology|October 15, 1995
A triplet of nuclease proteins (NP42-50) is activated in human Jurkat cells undergoing apoptosisC Zhang, M J Robertson, S F SchlossmanMolecular Immunology|December 1, 1988
Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytesT F Tedder, G McIntyre, S F SchlossmanJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1983
Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrainsG Klein, B Ehlin-Henriksson, S F SchlossmanPageof 69